# A Study on the Effect of Chemotherapy Combined With Anti-HIV Drugs in HIV-Positive Patients

> **NCT00000899** · PHASE1 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 10 (—)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Nelfinavir mesylate
- **DRUG:** Lamivudine
- **DRUG:** Filgrastim
- **DRUG:** Stavudine
- **DRUG:** Cyclophosphamide

## Key facts

- **NCT ID:** NCT00000899
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** 2001-10
- **Target enrollment:** 10 (—)
- **Last updated:** 2021-10-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00000899

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00000899, "A Study on the Effect of Chemotherapy Combined With Anti-HIV Drugs in HIV-Positive Patients". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT00000899. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*